Discover
TGTX
TG Therapeutics, Inc.
53.52
1 x 47.17
1 x 61.77
bid
ask
-
1.42
2.58%
1 @ 06:25 AM
53.94 +0.42 (0.78%)
| Ytd | 79.54% | |
| 1y | 51.19% |
53.50
day range
55.44
25.28
52 week range
57.38
| Open | 55.10 | Prev Close | 54.94 | Low | 53.50 | High | 55.44 | Mkt Cap | 8.19B |
| Vol | 1.99M | Avg Vol | 2.33M | EPS | 2.86 | P/E | 18.71 | Forward P/E | 18.63 |
| Beta | 1.68 | Short Ratio | 15.25 | Inst. Own | 70.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 42.89 | 200-d Avg | 34.54 | 1yr Est | 51.71 |
| Income Statement | |||
| Total Revenue | 204.92M | ||
| Revenues (USD) | 204.92M | ||
| Cost of Revenue | 33.51M | ||
| Gross Profit | 171.41M | ||
| Operating Expenses | 136.61M | ||
| Research and Development Expense | 48.40M | ||
| Selling, General and Administrative Expense | 88.22M | ||
| Operating Income | 34.80M | ||
| Interest Expense | 7.67M | ||
| Income Tax Expense | 586.00K | ||
| Net Income | 19.78M | ||
| Net Income Common Stock | 19.78M | ||
| Net Income Common Stock (USD) | 19.78M | ||
| Consolidated Income | 19.78M | ||
| Earnings per Basic Share | 0.14 | ||
| Earnings per Basic Share (USD) | 0.14 | ||
| Earnings per Diluted Share | 0.12 | ||
| Earning Before Interest & Taxes (EBIT) | 28.03M | ||
| Earning Before Interest & Taxes (USD) | 28.03M | ||
| Weighted Average Shares | 144.44M | ||
| Weighted Average Shares Diluted | 160.06M | ||
| Balance Sheet | |||
| Cash and Equivalents | 443.56M | ||
| Cash and Equivalents (USD) | 443.56M | ||
| Investments | 133.76M | ||
| Investments Current | 72.22M | ||
| Investments Non-Current | 61.54M | ||
| Trade and Non-Trade Receivables | 392.05M | ||
| Current Assets | 1.09B | ||
| Property, Plant & Equipment Net | 6.48M | ||
| Total Assets | 1.53B | ||
| Total Debt | 751.74M | ||
| Current Liabilities | 187.11M | ||
| Debt Non-Current | 751.74M | ||
| Total Liabilities | 945.71M | ||
| Accumulated Retained Earnings (Deficit) | -1.06B | ||
| Shareholders Equity | 583.13M | ||
| Shareholders Equity (USD) | 583.13M | ||
| Assets Non-Current | 441.87M | ||
| Total Debt (USD) | 751.74M | ||
| Deferred Revenue | 24.05M | ||
| Inventory | 155.38M | ||
| Liabilities Non-Current | 758.60M | ||
| Trade and Non-Trade Payables | 148.85M | ||
| Tax Assets | 344.14M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 32.00K | ||
| Net Cash Flow from Financing | 390.83M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 363.07M | ||
| Capital Expenditure | -51.00K | ||
| Issuance (Purchase) of Equity Shares | -99.23M | ||
| Issuance (Repayment) of Debt Securities | 492.66M | ||
| Net Cash Flow from Investing | -9.86M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -9.81M | ||
| Net Cash Flow from Operations | -17.89M | ||
| Share Based Compensation | 19.95M | ||